Abstract | BACKGROUND: METHODS: RESULTS: The serum CR-1 level was significantly higher in HCC patients than volunteer controls and it was also significantly higher in HBV-related HCC than HCV-related HCC. In addition, serum CR-1 level was correlated with serum alpha-feto- protein (AFP) in HBV-related HCC patients. The serum CR-1 was also higher in cirrhosis and chronic hepatitis than volunteer controls. The serum CR-1 in HBV-related cirrhosis was higher than chronic hepatitis B, but there was no significant difference between HCV-related cirrhosis and chronic hepatitis C. CONCLUSIONS: Serum CR-1 was higher in HCC patients and might serve as a complementary biomarker to clinical diagnosis of HBV-related HCC. The high level of serum CR-1 in HBV-related liver disease might be partly attributed to HBV infection.
|
Authors | Yingyu Zhang, Hongqin Xu, Xiumei Chi, Yuxiang Fan, Ying Shi, Junqi Niu |
Journal | Medicine
(Medicine (Baltimore))
Vol. 97
Issue 35
Pg. e11781
(Aug 2018)
ISSN: 1536-5964 [Electronic] United States |
PMID | 30170372
(Publication Type: Journal Article)
|
Chemical References |
- GPI-Linked Proteins
- Intercellular Signaling Peptides and Proteins
- Neoplasm Proteins
- TDGF1 protein, human
|
Topics |
- Adult
- Carcinoma, Hepatocellular
(blood, virology)
- Case-Control Studies
- Female
- GPI-Linked Proteins
(blood)
- Hepatitis B, Chronic
(blood, complications)
- Hepatitis C, Chronic
(blood, complications)
- Humans
- Intercellular Signaling Peptides and Proteins
(blood)
- Liver Cirrhosis
(blood, virology)
- Liver Neoplasms
(blood, virology)
- Male
- Middle Aged
- Neoplasm Proteins
(blood)
|